Trial
NCT02059967
Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Virginia Commonwealth University
Collaborators
National Cancer Institute (NCI)
Condition
Adenocarcinoma of the Lung
Intervention
Paclitaxel
Why stopped
Due to no accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-03-19